Navigation
Trademark Information
Application ID
Status
Date of Application
12 December 2014
Classes
5
Type
Device
State
Maharashtra
Country
Filing Mode
Branch Office
IP Office
MUMBAI
Used Since
03 April 2013
Valid / Upto
12 December 2034
Description
[Class : 5] Manufacturing And Trading Of Pharmaceutical, Veterinary And Sanitary Preparations; Dietetic Substances Adapted For Medical Use, Food For Babies; Plasters, Materials For Dressings; Materials For Stopping Teeth, Dental Wax; Disinfectants; Preparation For Destroying Vermin; Fungicides, Herbicides
Image (DEVICE)
Documents
| Examination Report |
Uploaded Documents
| 1 | Additional Representation Sheet | 12 Dec 2014 |
| 2 | TM-1 | 12 Dec 2014 |
| 3 | Reply to Exam Report (MIS-R) | 19 Jul 2017 |
| 4 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 15 Jun 2018 |
| 5 | Journal Copy | 20 Oct 2018 |
| 6 | Certificate | 18 Jan 2019 |
| 7 | TM-R(RENEWAL OF TRADE MARK) | 06 Dec 2024 |
Correspondence and Notices
| 1 | Dispatching of Examination Report for : 2861182 | 3796286 | 1875415 | 26 Jul 2016 |
| 2 | Hearing Notice (Show Cause) | 6083084 | 2755502 | 19 Mar 2018 |
| 3 | Hearing Notice (Adjourned) | 6327885 | 2881843 | 09 May 2018 |
| 4 | Hearing Notice (Adjourned) | 6675990 | 3103542 | 17 Jul 2018 |
| 5 | Tribunal Accepted Notice for : 2861182 | 6867619 | 3130086 | 23 Aug 2018 |
| 6 | O3 NOTICE | 18913957 | 6923445 | 27 Sep 2024 |
| 7 | RENEWAL INTIMATION LETTER | 19280880 | 09 Dec 2024 |
Frequently Asked Questions
When was the trademark applied?
The application for Vi-alb was made on 12 December 2014.
Who is the applicant for Vi-alb?
The trademark applicant for Vi-alb is VIRCHOW LABORATORIES.
In what class is the trademark applied to?
Vi-alb is applied in class(es) 5.
What is the status of the trademark application?
Application for Vi-alb is on Registered stage.
What is the application ID of the trademark?
Application Id allotted to Vi-alb is 2861182.
What is the type of trademark application?
Vi-alb filed with the Intellectual property office as a DEVICE.